UCP2 as a Cancer Target through Energy Metabolism and Oxidative Stress Control

Area of Science:

• Biochemistry
• Oncology
• Metabolic pathways

Background:

• Cancer remains a leading cause of death globally, necessitating improved early detection and treatment response markers.
• Technological advancements and focus on cellular metabolism are revealing new targets for personalized cancer therapies.
• Mitochondrial transporter uncoupling protein 2 (UCP2) expression is elevated in many cancers, highlighting its role in tumor metabolic reprogramming.

Purpose of the Study:

• To review the multifaceted roles of uncoupling protein 2 (UCP2) in cancer development and progression.
• To explore UCP2 as a potential biomarker and therapeutic target in various cancer types.
• To discuss the implications of UCP2 targeting in combination with existing cancer treatments.

Main Methods:

• Literature review of recent scientific publications on UCP2 in the tumor context.
• Analysis of UCP2's biochemical and physiological functions in cancer.
• Synthesis of UCP2's impact on cellular metabolism, oxidative stress, and anti-tumor immunity.

Main Results:

• UCP2 plays a key role in protecting cancer cells from oxidative stress.
• UCP2 influences tumor progression by altering glycolytic, oxidative, and calcium metabolism.
• UCP2 enhances anti-tumor immunity within the tumor microenvironment, potentially limiting cancer growth.

Conclusions:

• UCP2 exhibits pleiotropic roles in cancer, acting as a potential tumor biomarker.
• Targeting UCP2 (either inhibition or activation) could be a viable strategy for personalized cancer therapy.
• Modulating UCP2 activity, in conjunction with chemotherapy or immunotherapy, may improve treatment efficacy and patient outcomes.